Investors can contact the law firm at no cost to learn more about recovering their losses
LOS ANGELES, April 14, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Sarepta Therapeutics, Inc. (“Sarepta Therapeutics” or the “Company”) ( SRPT) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Sarepta investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
On March 16, 2023, Sarepta Therapeutics announced that the U.S. FDA's Office of Therapeutics has decided to hold an advisory committee meeting for SRP-9001 in advance of the May 29, 2023 regulatory action date. This news caused a drop in the price of the company's stock.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
[email protected]
310-692-8883
www.portnoylaw.com
Attorney Advertising
